Advertisement
Screener

SPYRE THERAPEUTICS, INC. (SYRE) Other Nonoperating Income (Expense)

2.0 / 5 stars · 23/57 Roast Me

SPYRE THERAPEUTICS, INC. Other Nonoperating Income (Expense)

SPYRE THERAPEUTICS, INC. (SYRE) reported Other Nonoperating Income (Expense) of -$4.61 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Other Income

us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-04

  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$4.61M.
  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$30.36M, a 1428.04% decline year-over-year.
  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$12.50M.
  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $40.33M.
  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2025 was $29.46M.
  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2024 was -$20.71M.
  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2023 was -$19.13M.
  • SPYRE THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2022 was -$7.00K.
Period endOther Nonoperating Income (Expense) 3 monthOther Nonoperating Income (Expense) 6 monthOther Nonoperating Income (Expense) 9 monthOther Nonoperating Income (Expense) 12 month
2026-06-30-$4.61M
10-Q · filed 2026-08-04
-$34.97M
10-Q · filed 2026-08-04
-$47.47M
derived: sum of 3 quarters · filed 2026-08-04
-$7.14M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$30.36M
10-Q · filed 2026-05-05
-$42.86M
derived: sum of 2 quarters · filed 2026-05-05
-$2.53M
derived: sum of 3 quarters · filed 2026-05-05
-$3.19M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$12.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$27.83M
derived: sum of 2 quarters · filed 2026-02-19
$27.17M
derived: sum of 3 quarters · filed 2026-08-04
$29.46M
10-K · filed 2026-02-19
2025-09-30$40.33M
10-Q · filed 2025-11-04
$39.67M
derived: sum of 2 quarters · filed 2026-08-04
$41.96M
10-Q · filed 2025-11-04
$41.14M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$656.00K
10-Q · filed 2026-08-04
$1.63M
10-Q · filed 2026-08-04
$812.00K
derived: sum of 3 quarters · filed 2026-08-04
-$17.99M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$2.29M
10-Q · filed 2026-05-05
$1.47M
derived: sum of 2 quarters · filed 2026-05-05
-$17.33M
derived: sum of 3 quarters · filed 2026-05-05
-$17.94M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$818.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$19.62M
derived: sum of 2 quarters · filed 2026-02-19
-$20.23M
derived: sum of 3 quarters · filed 2026-02-19
-$20.71M
10-K · filed 2026-02-19
2024-09-30-$18.80M
10-Q · filed 2025-11-04
-$19.41M
derived: sum of 2 quarters · filed 2025-11-04
-$19.89M
10-Q · filed 2025-11-04
-$41.29M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30-$610.00K
10-Q · filed 2025-08-05
-$1.09M
10-Q · filed 2025-08-05
-$22.48M
derived: sum of 3 quarters · filed 2026-02-19
-$20.14M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31-$483.00K
10-Q · filed 2025-05-08
-$21.88M
derived: sum of 2 quarters · filed 2026-02-19
-$19.53M
derived: sum of 3 quarters · filed 2026-02-19
-$19.54M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31-$21.39M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-19
-$19.05M
derived: sum of 2 quarters · filed 2026-02-19
-$19.06M
derived: sum of 3 quarters · filed 2026-02-19
-$19.13M
10-K · filed 2026-02-19
2023-09-30$2.34M
10-Q/A · filed 2024-11-18
$2.33M
derived: sum of 2 quarters · filed 2024-11-18
$2.26M
10-Q/A · filed 2024-11-18
$2.23M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$8.00K
10-Q/A · filed 2024-11-18
-$80.00K
10-Q/A · filed 2024-11-18
-$112.00K
derived: sum of 3 quarters · filed 2025-02-27
-$88.00K
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$72.00K
10-Q/A · filed 2024-11-18
-$104.00K
derived: sum of 2 quarters · filed 2025-02-27
-$80.00K
derived: sum of 3 quarters · filed 2025-02-27
-$75.00K
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$8.00K
derived: sum of 2 quarters · filed 2025-02-27
-$3.00K
derived: sum of 3 quarters · filed 2025-02-27
-$7.00K
10-K · filed 2025-02-27
2022-09-30$24.00K
10-Q · filed 2023-11-09
$29.00K
derived: sum of 2 quarters · filed 2023-11-09
$25.00K
10-Q · filed 2023-11-09
-$16.00K
derived: sum of 4 quarters · filed 2024-11-18
2022-06-30$5.00K
10-Q · filed 2023-08-11
$1.00K
10-Q · filed 2023-08-11
-$40.00K
derived: sum of 3 quarters · filed 2024-11-18
-$64.00K
derived: sum of 4 quarters · filed 2024-11-18
2022-03-31-$30.00K
10-Q · filed 2023-05-11
-$45.00K
derived: sum of 2 quarters · filed 2024-11-18
-$69.00K
derived: sum of 3 quarters · filed 2024-11-18
-$121.00K
derived: sum of 4 quarters · filed 2024-11-18
2021-12-31-$15.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18
-$39.00K
derived: sum of 2 quarters · filed 2024-11-18
-$91.00K
derived: sum of 3 quarters · filed 2024-11-18
-$122.00K
10-K/A · filed 2024-11-18
2021-09-30-$24.00K
10-Q · filed 2022-11-03
-$76.00K
derived: sum of 2 quarters · filed 2022-11-03
-$107.00K
10-Q · filed 2022-11-03
-$89.00K
derived: sum of 4 quarters · filed 2023-03-02
2021-06-30-$52.00K
10-Q · filed 2022-08-04
-$83.00K
10-Q · filed 2022-08-04
-$65.00K
derived: sum of 3 quarters · filed 2023-03-02
-$63.00K
derived: sum of 4 quarters · filed 2023-03-02
2021-03-31-$31.00K
10-Q · filed 2022-05-05
-$13.00K
derived: sum of 2 quarters · filed 2023-03-02
-$11.00K
derived: sum of 3 quarters · filed 2023-03-02
-$30.00K
derived: sum of 4 quarters · filed 2023-03-02
2020-12-31$18.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$20.00K
derived: sum of 2 quarters · filed 2023-03-02
$1.00K
derived: sum of 3 quarters · filed 2023-03-02
-$5.00K
10-K · filed 2023-03-02
2020-09-30$2.00K
10-Q · filed 2021-11-04
-$17.00K
derived: sum of 2 quarters · filed 2021-11-04
-$23.00K
10-Q · filed 2021-11-04
-$41.00K
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30-$19.00K
10-Q · filed 2021-08-05
-$25.00K
10-Q · filed 2021-08-05
-$43.00K
derived: sum of 3 quarters · filed 2022-03-08
-$55.00K
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31-$6.00K
10-Q · filed 2021-05-10
-$24.00K
derived: sum of 2 quarters · filed 2022-03-08
-$36.00K
derived: sum of 3 quarters · filed 2022-03-08
-$52.00K
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31-$18.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
-$30.00K
derived: sum of 2 quarters · filed 2022-03-08
-$46.00K
derived: sum of 3 quarters · filed 2022-03-08
-$63.00K
10-K · filed 2022-03-08
2019-09-30-$12.00K
10-Q · filed 2020-11-05
-$28.00K
derived: sum of 2 quarters · filed 2020-11-05
-$45.00K
10-Q · filed 2020-11-05
-$65.00K
derived: sum of 4 quarters · filed 2021-03-18
2019-06-30-$16.00K
10-Q · filed 2020-08-10
-$33.00K
10-Q · filed 2020-08-10
-$53.00K
derived: sum of 3 quarters · filed 2021-03-18
-$66.00K
derived: sum of 4 quarters · filed 2021-03-18
2019-03-31-$17.00K
10-Q · filed 2020-05-07
-$37.00K
derived: sum of 2 quarters · filed 2021-03-18
-$50.00K
derived: sum of 3 quarters · filed 2021-03-18
-$57.00K
derived: sum of 4 quarters · filed 2021-03-18
2018-12-31-$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
-$33.00K
derived: sum of 2 quarters · filed 2021-03-18
-$40.00K
derived: sum of 3 quarters · filed 2021-03-18
-$57.00K
10-K · filed 2021-03-18
2018-09-30-$13.00K
10-Q · filed 2019-11-06
-$20.00K
derived: sum of 2 quarters · filed 2019-11-06
-$37.00K
10-Q · filed 2019-11-06
-$44.00K
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30-$7.00K
10-Q · filed 2019-08-06
-$24.00K
10-Q · filed 2019-08-06
-$31.00K
derived: sum of 3 quarters · filed 2020-02-24
-$43.00K
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31-$17.00K
10-Q · filed 2019-05-07
-$24.00K
derived: sum of 2 quarters · filed 2020-02-24
-$36.00K
derived: sum of 3 quarters · filed 2020-02-24
-$48.00K
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31-$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
-$19.00K
derived: sum of 2 quarters · filed 2020-02-24
-$31.00K
derived: sum of 3 quarters · filed 2020-02-24
-$42.00K
10-K · filed 2020-02-24
2017-09-30-$12.00K
10-Q · filed 2018-11-08
-$24.00K
derived: sum of 2 quarters · filed 2018-11-08
-$35.00K
10-Q · filed 2018-11-08
-$47.00K
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30-$12.00K
10-Q · filed 2018-08-09
-$23.00K
10-Q · filed 2018-08-09
-$35.00K
derived: sum of 3 quarters · filed 2019-03-07
-$44.00K
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31-$11.00K
10-Q · filed 2018-05-08
-$23.00K
derived: sum of 2 quarters · filed 2019-03-07
-$32.00K
derived: sum of 3 quarters · filed 2019-03-07
-$41.00K
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
-$21.00K
derived: sum of 2 quarters · filed 2019-03-07
-$30.00K
derived: sum of 3 quarters · filed 2019-03-07
-$36.00K
10-K · filed 2019-03-07
2016-09-30-$9.00K
10-Q · filed 2017-11-07
-$18.00K
derived: sum of 2 quarters · filed 2017-11-07
-$24.00K
10-Q · filed 2017-11-07
-$25.00K
derived: sum of 4 quarters · filed 2018-03-13
2016-06-30-$9.00K
10-Q · filed 2017-08-09
-$15.00K
10-Q · filed 2017-08-09
-$16.00K
derived: sum of 3 quarters · filed 2018-03-13
-$17.00K
derived: sum of 4 quarters · filed 2018-03-13
2016-03-31-$6.00K
10-Q · filed 2017-05-09
-$7.00K
derived: sum of 2 quarters · filed 2018-03-13
-$8.00K
derived: sum of 3 quarters · filed 2018-03-13
2015-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
-$2.00K
derived: sum of 2 quarters · filed 2018-03-13
-$2.00K
10-K · filed 2018-03-13
2015-09-30-$1.00K
10-Q · filed 2016-11-09
-$1.00K
10-Q · filed 2016-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
CYTOKINETICS INC (CYTK)United States$9.130B-11.86